Berberine bisufate

The authors recommend berberine bisulfate for use as thrombocytopoiesis stimulator in thrombocytopenias as they have found secondary therapeutic property of this drug--to increase platelet count in patients with primary and secondary thrombocytopenia. The drug was given as monotherapy and in combined treatment 3 times a day for 15 days in a dose 5 mg 20 min before meals.